Elevated cTnT levels occur in 5–36% of patients with acute ischemic stroke (AIS)[3–12], and they are associated with greater stroke severity on admission and higher risk of insular lobe damage, poor clinical outcome and mortality[7,11,13]. This evidence concerns the gene TNNT2 and androgen insensitivity syndrome.